J&J: Sirturo significantly improved treatment outcomes in patients with rifampicin-resistant tuberculosis.
83% of participants on an oral Sirturo-containing regimen achieved a favorable outcome compared to 71% of patients on the control ...
Tag: tuberculosis
The 2 Minute Medicine Podcast Episode 25
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: Company Cuts TB Testing Cost, Guillain-Barre Syndrome Struggles for Stevens, Medical Abortion Tests, and Blood Supply Shortages
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
#VisualAbstract: Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India
Click here to read this study in The Lancet. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may ...
#VisualAbstract: Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior to standard 24-week treatment for tuberculosis. 2. The ...
Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior to standard 24-week treatment for tuberculosis. 2. The ...
![Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/TB-original-e1591582219420-350x250.jpg)
Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis
1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in lower mortality, treatment failure, and discontinuation compared ...
Two bedaquiline-containing regimens had superior efficacy and safety profiles for treatment of rifampin-resistant tuberculosis
1. Compared to a 9-month injectable-containing (control) regimen, both bedaquiline-containing oral regimens had more favourable outcomes, such as negative cultures. ...
#VisualAbstract: All-oral regimen with delamanid, linezolid, levofloxacin, and pyrazinamide is effective for fluoroquinolone-sensitive multidrug-resistant tuberculosis
1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group versus conventional therapy, satisfying the noninferiority ...
All-oral regimen with delamanid, linezolid, levofloxacin, and pyrazinamide is effective for fluoroquinolone-sensitive multidrug-resistant tuberculosis
1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group versus conventional therapy, satisfying the noninferiority ...